Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 3 clinical trials
Eltrombopag Plus Diacerein vs Eltrombopag in Adult ITP

Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder with low platelet count. As the first choice of the second-line treatment of ITP, thrombopoietin receptor agonist (TPO-RA

platelet count
eltrombopag
  • 1 views
  • 19 Jun, 2021
  • 1 location
Immunomodulation With Eltrombopag in ITP (iROM2)

The study aims to investigate immunomodulatory effects of eltrombopag combined with dexamethasone in young adult patients with newly diagnosed primary Immune thrombocytopenia (ITP).

  • 0 views
  • 17 Mar, 2022
  • 6 locations
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors

is that eltrombopag an oral thrombopoietin receptor agonist will increase the platelet count safely and efficaciously in children having chemotherapy induced thrombocytopenia while on therapy for

  • 0 views
  • 02 Aug, 2021
  • 1 location